Please login to the form below

Not currently logged in

Cardax adds big pharma experience to board

Brings in former Novartis, BMS and Boehringer executives

tamar howson cardaxHawaii-based anti-inflammatory specialist Cardax has added three new members to its board, each with experience at a major pharma company.

George Bickerstaff is a former chief financial officer of Novartis who is now managing director at investment bank MM Dillon. He was also chief financial officer at IMS Health.

Tamar Howson (pictured right) is a former senior business development executive at Bristol-Myers Squibb and SmithKline Beecham (now GSK) who now acts as an independent consultant to life sciences companies.

The final new addition is Terence Kelly who provides Cardax with scientific experience having served as VP, department of medicinal chemistry at Boehringer Ingelheim. He is currently president and CEO of CoMentis, a private biotech company focused on neurodegenerative diseases.

“The distinctive, yet complementary skills of our new board members provide a strong foundation as we develop and commercialise our nutraceutical and pharmaceutical programmes,” said David Watumull, president and CEO of Cardax.

These programmes are focused on developing products that are as effective as steroids and NSAIDS but have safer profiles.

19th June 2014

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...